Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Work
Year: 2004
Type: article
Source: Nature Medicine
Authors Christopher G. Willett, Yves Boucher, Emmanuelle di Tomaso, Dan G. Duda, Lance L. Munn +18 more
Institutions Harvard University Press, Massachusetts General Hospital, Harvard University, National Institutes of Health
Cites: 15
Cited by: 1,948
Related to: 10
FWCI: 59.24
Citation percentile (by year/subfield): 100
Subfield: Molecular Biology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green